Amarin Corp Plcuk (AMRN) EPS (Diluted) (QoQ) (2011 - 2026)

Amarin Corp Plcuk (AMRN) EPS (Diluted) (QoQ) (2011 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -750.48%
Dec 31, 2025 84.16%
Sep 30, 2025 45.41%
Jun 30, 2025 10.15%
Mar 31, 2025 -541.85%
Dec 31, 2024 -93.54%
Sep 30, 2024 -1,752.36%
Jun 30, 2024 100.76%
Mar 31, 2024 -3,322.44%
Dec 31, 2023 70.01%
Sep 30, 2023 -9.82%
Jun 30, 2023 -6.25%
Mar 31, 2023 -1,999.12%
Dec 31, 2022 116.80%
Sep 30, 2022 92.77%
Jun 30, 2022 -121.43%
Mar 31, 2022 -317.27%
Dec 31, 2021 210.14%
Sep 30, 2021 -270.62%
Jun 30, 2021 571.68%